The grant will support the development of an automated, cartridge-based desktop testing instrument for direct-from-blood detection of yeast infections.

The private equity firms invested along with executive Cary Breese, who is slated to become CEO of the clinical lab.

The company plans to launch in 2026 a program that will provide labs with scanners free of charge in exchange for volume-based payments for biomarker tests.

The company recently published a study showing that elemental patterns in single strands of hair are different in patients with ALS.

NEW YORK — Quest Diagnostics has struck a deal to use healthcare software firm Epic Systems' suite of enterprise laboratory software and services, the companies said on Tuesday.

The agency said that it will during emergencies balance the risks of delaying access to tests compared with the risks of harm from inaccurate test results.

The agency said that it will during emergencies balance the risks of delaying access to tests compared with the risks of harm from inaccurate test results.

Stakeholders noted that challenges like supply chain breakdowns and staffing shortages are too global in scope for any one ...

The companies will initially focus on the development of companion diagnostics that can be used in research and clinical trials in collaborations with pharma companies.

AD, the test measures epigenetic markers in mitochondrial DNA to assess the likelihood that a person with mild cognitive impairment will progress to dementia.

Helio Diagnostics will help with feasibility and development, performance verification, analytical and clinical validation, industrialization and tech transfer, and more.

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...